MDXH — MDxHealth SA Income Statement
0.000.00%
Last trade - 00:00- €81.66m
- €89.02m
- $37.05m
Annual income statement for MDxHealth SA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 28.4 | 11.8 | 18.5 | 22.2 | 37.1 |
| Cost of Revenue | |||||
| Gross Profit | 16.4 | -0.144 | 7.94 | 10.4 | 19.2 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 60.5 | 55 | 45.6 | 49.1 | 75 |
| Operating Profit | -32.1 | -43.2 | -27.1 | -26.8 | -37.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -32.5 | -43.7 | -28.7 | -29 | -44 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -32.5 | -43.1 | -28.7 | -29 | -44 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -32.5 | -43.1 | -28.7 | -29 | -44 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -32.5 | -43.1 | -28.7 | -29 | -44 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -5.63 | -6.23 | -3.41 | -2.38 | -2.77 |
| Dividends per Share |